1
ChemInform 2009, 40, issue 08 © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.cheminform.wiley-vch.de Pyridine derivatives R 0380 Triazole Oxytocin Antagonists: Identification of Aryl Ether Replacements for a Biaryl Substituent. — Putative overlap of known oxytocin antagonists is used to iden- tify aryl ether left-hand side substituents as replacements for biaryl substituents. Com- pound (VIII), exhibiting significantly improved aqueous solubility, is a selective and potent oxytocin antagonist and represents one of the most ligand efficient oxytocin antagonists. — (BROWN*, A.; BROWN, L.; BROWN, T. B.; CALABRESE, A.; ELLIS, D.; PUHALO, N.; SMITH, C. R.; WALLACE, O.; WATSON, L.; Bioorg. Med. Chem. Lett. 18 (2008) 19, 5242-5244; Dep. Chem., Pfizer Global Res. Dev., Sandwich, Kent CT13 9NJ, UK; Eng.) — H. Hoennerscheid 08- 163

ChemInform Abstract: Triazole Oxytocin Antagonists: Identification of Aryl Ether Replacements for a Biaryl Substituent

Embed Size (px)

Citation preview

Page 1: ChemInform Abstract: Triazole Oxytocin Antagonists: Identification of Aryl Ether Replacements for a Biaryl Substituent

www.cheminform.wiley-vch.de

Pyridine derivativesR 0380 Triazole Oxytocin Antagonists: Identification of Aryl Ether Replacements for a

Biaryl Substituent. — Putative overlap of known oxytocin antagonists is used to iden-tify aryl ether left-hand side substituents as replacements for biaryl substituents. Com-pound (VIII), exhibiting significantly improved aqueous solubility, is a selective and potent oxytocin antagonist and represents one of the most ligand efficient oxytocin antagonists. — (BROWN*, A.; BROWN, L.; BROWN, T. B.; CALABRESE, A.; ELLIS, D.; PUHALO, N.; SMITH, C. R.; WALLACE, O.; WATSON, L.; Bioorg. Med. Chem. Lett. 18 (2008) 19, 5242-5244; Dep. Chem., Pfizer Global Res. Dev., Sandwich, Kent CT13 9NJ, UK; Eng.) — H. Hoennerscheid

08- 163

ChemInform 2009, 40, issue 08 © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim